Institute for International Research

Providing Insights for Optimizing All Phases of the Transfer Process

14 Case Studies on All Phases of the Transfer Process from Industry Leaders, Including: Amgen Inc. Avecia Biologics, United Kingdom Bayer HealthCare AG, Germany Boehringer Ingelheim RCV GmbH & Co KG, Austria Bristol-Myers Squibb Co. Celltrion, Inc., Korea Eli Lilly and Company Genentech, Inc. Human Genome Sciences Inc. Pfizer Inc Wyeth Biopharma, Ireland These case studies provide the most recent unpublished data that you can use to ensure the success of your transfers. Get the Most Out of your Budget with our Concurrent Conferences and Dual Conference Pass We have conveniently co-located and concurrently scheduled IBC's 5th International Outsourcing Manufacturing of Biopharmaceuticals and IBC's 13th International Process Validation for Biopharmaceuticals Conferences. These conferences are just prior to IBC's 22nd International Antibody Development and Production and IBC's Inaugural Non-Antibody Protein Therapeutics events. We offer significant discounts for attending the week-long event and encourage attendees to take advantage of our Dual Conference Pass.

IBC's 4th Annual Technology Transfer for Biopharmaceuticals will provide you with industry insights and "lessons learned" to help you to overcome the complexities and avoid the potential pitfalls of method and process transfers. This two day program features 14 exclusive case studies that will cover the entire lifecycle of internal, external and international technology transfers, giving you proven approaches to ensure the success of your current and future transfers.

By attending, you will learn:

• How to develop sustainable business processes for technology transfer
• Best practices for successful project management of process transfers
• Strategies to developing a process that is robust and transferrable
• Keys to implementing QbD principles during technology transfers
• Overcoming facility fit challenges for high capacity processes
• Benefits and pitfalls in dealing with CMOs

Plus, joint presentations providing perspectives from both the donor and recipient sites.

Keynote Presentation:
Failed Tech Transfers: Learning our Lessons the Hard Way
E. Morrey Atkinson, Ph.D., Director, Bioprocess R&D, Eli Lilly and Company

Featured Presentation:
Application of Quality by Design Principles during Process Technology Transfer Enda Moran, Ph.D., Associate Director, Process Development, Wyeth Biotech, Ireland

In-Depth Coverage of Critical Issues, Including:

• Project Management: Providing best practices that you can immediately apply to ensure a successful transfer
• Business Strategies: Delivering sustainable business practices and tools to help you implement, measure and manage your platforms and current initiatives
• Process Development: Supplying proven approaches to maximize your success though the development of robust and transferable processes
• Facility Fit: Gaining operational and engineering insights and solutions to overcome your challenges for high capacity processes